SCHEMBL4599436

SCHEMBL4599436

COc1ccc(CNc2[c]ccc(Br)c2)c(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.54
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
DHFR P00374 1/20 0.44
NPC1 O15118 1/20 0.44
PKM P14618 1/20 0.44
RAB9A P51151 1/20 0.44
ERBB2 P04626 1/20 0.43
PRKACA P17612 1/20 0.43
RPS6KB1 P23443 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
IRAK1 P51617 1/20 0.43
RPS6KA3 P51812 1/20 0.43
ROCK1 Q13464 1/20 0.43
CDC42BPA Q5VT25 1/20 0.43
AURKB Q96GD4 1/20 0.43
CSNK1G3 Q9Y6M4 1/20 0.43
TSHR P16473 9/20 0.42
CYP1A2 P05177 7/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599467 0.84 APLNR (0.54) APLNRHTR2AHTR2CDHFRNPC1
SCHEMBL4599690 0.84 APLNR (0.54) APLNRHTR2AHTR2CDHFRNPC1
SCHEMBL4599375 0.81 MAPT (0.55) NPC1PKMRAB9ALMNAALDH1A1
SCHEMBL4599680 0.79 MAPT (0.52) APLNRDHFRNPC1PKMRAB9A
SCHEMBL4600346 0.79 APLNR (0.48) APLNRDHFRNPC1PKMRAB9A
SCHEMBL4599421 0.77 MAOB (0.50) APLNRNPC1PKMRAB9ATSHR
SCHEMBL4610582 0.75 ALDH1A1 (0.45) APLNRDHFRNPC1PKMRAB9A
SCHEMBL4710973 0.74 APLNR (0.51) APLNRHTR2ADHFRNPC1PKM
SCHEMBL27972158 0.74 APLNR (0.54) APLNRHTR2AHTR2CDHFRNPC1
SCHEMBL27948920 0.72 APLNR (0.69) APLNRDHFRNPC1PKMRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed